89 related articles for article (PubMed ID: 3691644)
1. Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
McKenna DJ; Saavedra JM
Eur J Pharmacol; 1987 Oct; 142(2):313-5. PubMed ID: 3691644
[No Abstract] [Full Text] [Related]
2. LSD or DOB?
Davis WM
Am J Psychiatry; 1982 Dec; 139(12):1649. PubMed ID: 7149079
[No Abstract] [Full Text] [Related]
3. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
4. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
Otaka T
Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
[No Abstract] [Full Text] [Related]
5. Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand.
McKenna DJ; Nazarali AJ; Hoffman AJ; Nichols DE; Mathis CA; Saavedra JM
Brain Res; 1989 Jan; 476(1):45-56. PubMed ID: 2536576
[TBL] [Abstract][Full Text] [Related]
6. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Pierce PA; Peroutka SJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
[TBL] [Abstract][Full Text] [Related]
8. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
Nichols DE
J Theor Biol; 1976 Jun; 59(1):167-77. PubMed ID: 7711
[No Abstract] [Full Text] [Related]
9. Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2, 5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms.
Niwaguchi T; Inoue T
J Chromatogr; 1976 Jun; 121(1):165-9. PubMed ID: 932131
[No Abstract] [Full Text] [Related]
10. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
11. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
12. QSAR studies on psychotomimetic phenylalkylamines.
Gupta SP; Handa A; Bindal MC; Singh P
Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
[TBL] [Abstract][Full Text] [Related]
13. A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in the brain tissue.
Eckler JR; Greizerstein H; Rabin RA; Winter JC
J Pharmacol Toxicol Methods; 2001; 46(1):37-43. PubMed ID: 12164258
[TBL] [Abstract][Full Text] [Related]
14. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.
Muschamp JW; Regina MJ; Hull EM; Winter JC; Rabin RA
Brain Res; 2004 Oct; 1023(1):134-40. PubMed ID: 15364028
[TBL] [Abstract][Full Text] [Related]
15. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
[TBL] [Abstract][Full Text] [Related]
17. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
18. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
Mokler DJ; Commissaris RL; Warner MR; Rech RH
J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
[TBL] [Abstract][Full Text] [Related]
19. R(-)-2,5-dimethoxy-4-77 bromoamphetamine [77Br-R(-)DOB]: a novel radioligand which labels a 5-HT binding site subtype.
Wang SS; Mathis CA; Peroutka SJ
Psychopharmacology (Berl); 1988; 94(3):431-2. PubMed ID: 3357926
[TBL] [Abstract][Full Text] [Related]
20. Effects of 2,5-dimethoxy-4-methylamphetamine on the behavior of rats in competition for food.
Uyeno ET
Int Pharmacopsychiatry; 1972; 7(1-4):244-8. PubMed ID: 4681210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
